drugset / Trial / NCT05713877

Melatonin for Treatment of Delirium in Critically Ill Adult Patients

NCT05713877

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the feasibility of conducting a randomized controlled trial (RCT) with melatonin for treatment of delirium in critically ill adult patients. From a feasibility perspective, the investigators believe that the proposed design will achieve the minimum enrollment rate necessary to conduct a future RCT on a larger scale.

Timeline

Start
2023-02-01
Primary completion
2026-12-30
Completion
2026-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 9 mg Oral

Indications